Details of the Drug

General Information of Drug (ID: DMD2O00)

Drug Name

JNJ-39758979

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C11H19N5
Canonical SMILES: CC(C)C1=CC(=NC(=N1)N)N2CCC(C2)N
InChI: 1S/C11H19N5/c1-7(2)9-5-10(15-11(13)14-9)16-4-3-8(12)6-16/h5,7-8H,3-4,6,12H2,1-2H3,(H2,13,14,15)/t8-/m1/s1
InChIKey: COOGVHJHSCBOQT-MRVPVSSYSA-N

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00946569) A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma. U.S. National Institutes of Health.